Horizon Therapeutics Revenue and Competitors

Chicago, IL USA

Location

$2.7B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Horizon Therapeutics's estimated annual revenue is currently $3B per year.(i)
  • Horizon Therapeutics's estimated revenue per employee is $843,786
  • Horizon Therapeutics's total funding is $2.7B.
  • Horizon Therapeutics's current valuation is $20.7B. (January 2022)

Employee Data

  • Horizon Therapeutics has 3508 Employees.(i)
  • Horizon Therapeutics grew their employee count by -5% last year.

Horizon Therapeutics's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
Group VP M&A and Business DevelopmentReveal Email/Phone
3
CFOReveal Email/Phone
4
Sr. VP CM Operations and Supply ChainReveal Email/Phone
5
Group VP, Field Medical Affairs and OperationsReveal Email/Phone
6
Group VP and General Manager, Gout and Inflammation Business UnitsReveal Email/Phone
7
CIOReveal Email/Phone
8
Head Research and Development Compliance and Standards and Clinical Core FunctionsReveal Email/Phone
9
VP Rheumatology Clinical ResearchReveal Email/Phone
10
VP New Product PlanningReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M285214%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Horizon Therapeutics?

Horizon Therapeutics is a late stage biopharmaceutical company focused on rapid development of prescription drugs for mild to moderate pain relief. We are creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.

keywords:N/A

$2.7B

Total Funding

3508

Number of Employees

$3B

Revenue (est)

-5%

Employee Growth %

$20.7B

Valuation

N/A

Accelerator

Horizon Therapeutics News

2022-04-19 - Should You Buy Horizon Therapeutics PLC (HZNP) in Drug Manufacturers - General Industry?

Horizon Therapeutics PLC (HZNP) is the highest overall rated company in the Drug Manufacturers - General industry with an overall score of...

2022-04-13 - Horizon Therapeutics and Massachusetts Institute of ...

Horizon Therapeutics and Massachusetts Institute of Technology (MIT) Solve Announce Second Annual Horizon Prize to Inspire Solutions that...

2022-04-06 - Horizon Therapeutics plc to Release First-Quarter 2022 ...

Horizon Therapeutics plc to Release First-Quarter 2022 Financial Results and Host Webcast on May 4, 2022. April 14, 2022 08:00 AM Eastern...

2021-05-05 - HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Horizon Therapeutics Public : Press Release of Horizon Therapeutics plc, dated May 5, 2021

Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc. - First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1567.7M45523%N/A
#2
$1258.5M5014-1%N/A
#3
$1634.6M51214%N/A
#4
$4540M5720-7%$181.9M
#5
$7400M61263%N/A